This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovations of Richard G. Lynch
Introduction
Richard G. Lynch is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of immunology through his innovative work on gene sequences. His research focuses on the development of a soluble form of the immuno-regulatory protein CD23, which plays a crucial role in regulating IgE levels in the blood.
Latest Patents
Richard G. Lynch holds 1 patent for his invention titled "DNA sequences for soluble form of CD23." This patent discloses the isolation and purification of gene sequences that, upon expression, produce a soluble form of CD23. This protein is essential for regulating the amount of IgE present in the bloodstream. The cloning and amplification of this protein may lead to new treatment options for IgE-mediated diseases.
Career Highlights
Lynch is affiliated with the University of Iowa Research Foundation, where he continues to advance his research in immunology. His work has the potential to impact the treatment of various allergic conditions and diseases related to IgE.
Collaborations
Richard G. Lynch has collaborated with esteemed colleagues such as Junji Yodoi and Rafael M. Nunez. Their combined expertise has contributed to the advancement of research in the field of immunology.
Conclusion
Richard G. Lynch's innovative work on the soluble form of CD23 represents a significant advancement in immunology. His contributions may pave the way for new therapeutic approaches to treat IgE-mediated diseases.